Transaction DateRecipientSharesTypePriceValue
Atossa Therapeutics
Atossa Therapeutics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008.

Ticker: ATOS
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1488039
Employees: 6
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags